1. Home
  2. CRVS vs EYE Comparison

CRVS vs EYE Comparison

Compare CRVS & EYE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$11.74

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Logo National Vision Holdings Inc.

EYE

National Vision Holdings Inc.

HOLD

Current Price

$16.37

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRVS
EYE
Founded
2014
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Ophthalmic Goods
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.3B
IPO Year
2016
2017

Fundamental Metrics

Financial Performance
Metric
CRVS
EYE
Price
$11.74
$16.37
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
6
9
Target Price
$30.17
★ $31.22
AVG Volume (30 Days)
912.0K
★ 2.1M
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
48.04
★ 202.78
EPS
N/A
★ 0.54
Revenue
N/A
★ $1,987,488,000.00
Revenue This Year
N/A
$5.56
Revenue Next Year
N/A
$6.58
P/E Ratio
★ N/A
$29.85
Revenue Growth
N/A
★ 9.00
52 Week Low
$6.39
$14.75
52 Week High
$26.95
$30.02

Technical Indicators

Market Signals
Indicator
CRVS
EYE
Relative Strength Index (RSI) 36.59 40.13
Support Level $11.13 $16.05
Resistance Level $13.73 $17.77
Average True Range (ATR) 0.71 0.75
MACD -0.11 0.07
Stochastic Oscillator 24.05 29.59

Price Performance

Historical Comparison
CRVS
EYE

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

About EYE National Vision Holdings Inc.

National Vision Holdings Inc. is an optical retailer in the United States. Its product portfolio includes eyeglasses, sunglasses, contact lenses, accessories, and other related products. The company operates through a single operating segment. The Owned and Host segment includes the company-owned brands America's Best and Eyeglass World. In America's Best stores, vision care services are provided by optometrists or by independent professional corporations. The Host segment consists of Military and Fred Meyer locations, where eye exams are provided by independent optometrists.

Share on Social Networks: